Hodgkin lymphoma in temporal association with growth hormone replacement.

Abstract

The association between growth hormone (GH) replacement and malignancy has long been debated. We report a case of Hodgkin lymphoma that developed in temporal association with the initiation of GH replacement in a 57-year-old woman with panhypopituitarism secondary to a non-secretory pituitary macroadenoma. Treatment of her pituitary tumor included transphenoidal surgery, external beam radiation, Bromocriptine and Cabergaline therapy. In addition to replacement steroid, thyroid and sex hormones, she insisted on GH replacement. Approximately 2 years after GH initiation, the diagnosis of Hodgkin lymphoma was made. Although the exact contribution of GH to the development of Hodgkin disease in our patient is unclear and a causal effect cannot be concluded, the temporal association is suggestive, and warrants reporting as part of ongoing surveillance for potential complications of GH replacement.

• Authors: Renee J Freedman, Vera Malkovska, Derek LeRoith, Michael T Collins
• Journal: Endocrine journal (Endocr J) Vol. 52 Issue 5 Pg. 571-5 (Oct 2005) ISSN: 0918-8959 [Print] Japan
• PMID: 16284435 (Publication Type: Case Reports, Journal Article)

Chemical References

• Human Growth Hormone

Topics

• Adenoma (therapy)
• Adult
• Female
• Hodgkin Disease (chemically induced)
• Human Growth Hormone (adverse effects, therapeutic use)
• Humans
• Middle Aged
• Pituitary Neoplasms (therapy)